Senior insider sale
ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$384.9K
9.09K shares
What this filing means
ORBIMED ADVISORS LLC plans to sell 9.09K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $384.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/16/2026ACC: 0000947871-26-000627
Director10% Owner
Since Mar 2020
9.09K
Shares to sell
$384.9K
Approx. market value
9.09K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Merger
N/A
2/23/2023
9.09KTotal acquired9.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2023 | Merger N/A | 9.09K | — |
| Total | 9.09K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
9.09K
Market value
$384.9K
6/15/2026
Total
Units
9.09K
Value
$384.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2026 | 9.09K | $384.9K | Nasdaq Stock Market | Planned |
| Total | 9.09K | $384.9K | ||